All News

FDA accepted Impel’s new drug application (NDA) for TRUDHESA last month.

Not to be outdone by the showbiz industry, Pharm Exec's own awards season is fast approaching.

Report highlights how lung cancer progress in diagnosis has been pushed back, with further impact on treatment likely as the pandemic continues.

Week-long event aims to help commercialize innovations to reach patients in need.

Embracing the new, holistic views of pharma in 2021.

Panel will provide guidance around evolving digital business models.

Lead company is seeking others to join the initiative.

Mike Hennessey Sr., Chairman and Founder of MJH Life Sciences, pushes for the celebration of the pharmaceutical industry after nine grueling months of fighting COVID-19.

Prescription opioid Use in the U.S. has declined by 60% from 2011 Peak, according to new report from IQVIA.

Survey shows providers have embraced telemedicine, but are experiencing higher rates of burnout.

Companies previously signed an agreement to supply a total of 40 million doses to the UK with delivery in 2020 and 2021.

10th Annual Best Places to Work in Medical Sales survey polled over 2,000 professionals.

New customer reference data survey looks at the current state of customer reference data within life sciences across Europe.

Company will form broad-scale strategic partnerships with industry leaders in claims, EMR, formulary and provider-institutional data.

GlobalData releases report on the physician's perspective of telemedicine.

Following the announcement of his new role, Pharm Exec had the chance to speak with Daniel Schroen, PhD about his past experience as well as the landscape of the therapeutic development industry.

Previewing executive trends thought of by leaders in the pharma industry.

AI-powered platform can transform medical expert and opinion leader engagement planning for medical affairs teams.

Pharmaceutical R&D industry report provides insights into what’s behind decline in global NME outputs and reveals implications of decreased projected expenditures.

Women’s leadership and mentoring initiatives garner Healthcare Businesswomen’s Association top honors for BD, GSK, Surgical Care Affiliates, and Walgreens Boots Alliance.

Theme for this year's virtual event is delivering digital impact at scale.

A technology-enabled solution combining predictive analytics integrated with real-time commercial services for the life sciences sector.

In this September 2020 Product Launch issue of Pharm Exec, we highlight five products, all approved in 2019, and showcase what is now their early brand journey.

Multicultural campaigns crafted for diverse populations are insufficiently funded and do not receive the same support as mainstream campaigns, writes Sheila Thorne. While there are plenty of people willing to partner with pharma on these campaigns, will the industry wake up to the changing world ahead?

Review platform launches in light of new research which reveals that 93% lack trust in pharma companies.

Bioscience firm applies AI and data science to identify existing drugs Atozet and Cablivi as potentially effective therapies for blood clots and inflammation caused by COVID-19.

COVID-19 has only magnified well known flaws of our healthcare system. An extension of Medicare is the affordable solution, writes Bruno Delagneau, and pharma needs to start planning for this to minimize its impact on US revenues.

Dr. Manuel Hermosilla shares his thoughts on how the pharmaceutical industry reacts to challenges that arise during trials, specifically during the search for an effective COVID-19 vaccine.